Simple screening tests for peripheral neuropathy in the diabetes clinic.

[1]  Preventive foot care in people with diabetes. , 2000, Diabetes care.

[2]  A. Vinik.  Diabetic neuropathy: pathogenesis and therapy. , 1999, The American journal of medicine.

[3]  M. Wallhagen,et al.  Identifying diabetic patients at high risk for amputation. , 1999, The Nurse practitioner.

[4]  A. Boulton.  Lowering the risk of neuropathy, foot ulcers and amputations , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[5]  I. Tkáč,et al.  Glycemic Control Is Related to the Electrophysiologic Severity of Diabetic Peripheral Sensorimotor Polyneuropathy , 1998, Diabetes Care.

[6]  Lawrence A Leiter,et al.  1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[7]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[8]  R. Mazze,et al.  Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. , 1998, The Journal of family practice.

[9]  P. Raskin,et al.  Double‐blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy , 1998, Neurology.

[10]  D. Armstrong,et al.  Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. , 1998, Archives of internal medicine.

[11]  V. Bril,et al.  Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group. , 1998, Muscle & nerve.

[12]  R. Heine,et al.  The prevalence and determinants of foot ulceration in type II diabetic patients in a primary health care setting. , 1997, Diabetes research and clinical practice.

[13]  L. Bouter,et al.  The assessment of diabetic polyneuropathy in daily clinical practice: Reproducibility and validity of Semmes Weinstein monofilaments examination and clinical neurological examination , 1997, Muscle & nerve.

[14]  P. Dyck,et al.  Pathologic Alterations in the Diabetic Neuropathies of Humans: A Review , 1996, Journal of neuropathology and experimental neurology.

[15]  A. Boulton,et al.  Why bother educating the multi-disciplinary team and the patient--the example of prevention of lower extremity amputation in diabetes. , 1995, Patient education and counseling.

[16]  S. Simon,et al.  The Semmes–Weinstein Monofilament as a Potential Predictor of Foot Ulceration in Patients With Noninsulin‐Dependent Diabetes , 1995, The American journal of the medical sciences.

[17]  V. Bril.  Role of Electrophysiological Studies in Diabetic Neuropathy , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  M B Brown,et al.  A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.

[19]  A. Veves,et al.  The Prediction of Diabetic Neuropathic Foot Ulceration Using Vibration Perception Thresholds: A prospective study , 1994, Diabetes Care.

[20]  P. Reichard,et al.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.

[21]  S. Rith-Najarian,et al.  Identifying Diabetic Patients at High Risk for Lower-Extremity Amputation in a Primary Health Care Setting: A prospective evaluation of simple screening criteria , 1992, Diabetes Care.

[22]  A. K. Sharma,et al.  The Relationship Between Sural Nerve Morphometric Findings and Measures of Peripheral Nerve Function in Mild Diabetic Neuropathy , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[23]  P. Reichard,et al.  Intensified conventional insulin treatment retards the microvascular complications of insulin‐dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years , 1991, Journal of internal medicine.

[24]  L. Melton,et al.  The Rochester Diabetic Neuropathy Study , 1991, Neurology.

[25]  S. Britland,et al.  Association of Painful and Painless Diabetic Polyneuropathy With Different Patterns of Nerve Fiber Degeneration and Regeneration , 1990, Diabetes.

[26]  G. Reiber,et al.  Pathways to Diabetic Limb Amputation: Basis for Prevention , 1990, Diabetes Care.

[27]  G A Colditz,et al.  The economic costs of non-insulin-dependent diabetes mellitus. , 1989, JAMA.

[28]  M. B. Brown,et al.  Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. , 1988, The New England journal of medicine.

[29]  R. Kahn.  Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy , 1988, Diabetes Care.

[30]  F. Buchthal,et al.  Sensory action potentials and biopsy of the sural nerve in neuropathy. , 1978, Brain : a journal of neurology.

[31]  H. Babcock,et al.  Association of a , 1955 .